NDC 82501-0733-01 - Goodnow Cold and Flu Day Relief Cold and Flu Night Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82501-0733
- Requested NDC
- 82501-0733-01
- Package NDCs from labels
- 82501-0733-1, 82501-0733-01
- Manufacturer
- Gobrands, Inc
- Effective date
- 2026-10-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Goodnow Cold and Flu Day Relief Cold and Flu Night Relief - Gobrands, Inc | Gobrands, Inc | 2026-10-09 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82501-0459-0 | Goodnow Cold and Flu Day Relief Cold and Flu Night Relief | 355 mL in 1 BOTTLE | SOLUTION | 355 mL | 650 mg in 30mL | 1 |
| 82501-0656-0 | Goodnow Cold and Flu Day Relief Cold and Flu Night Relief | 355 mL in 1 BOTTLE | SOLUTION | 355 mL | 10 mg in 15mL | 1 |
| 82501-0733-1 | Goodnow Cold and Flu Day Relief Cold and Flu Night Relief | 1 in 1 CARTON | KIT | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks NyQuil COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efe4e649-7514-32dd-e053-2995a90a0492 | 2026-10-05 | Warnings | M012 9D2RTI9KYH V9BI9B5YI2 362O9ITL9D |
| Vicks DayQuil and Vicks NyQuil COLD and FLU | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | efb92829-1007-1c5d-e053-2a95a90a3c9b | 2026-10-05 | Warnings | M012 |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 04dc3835-64be-d9e4-e063-6394a90a8599 | 2026-10-05 | Warnings | M012 1113705 1043400 2637726 |
| Vicks DayQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fc9a43d8-0359-9def-e053-6294a90a7e91 | 2026-10-05 | Warnings | M012 1113705 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9a6f7e-32c1-9ded-e053-6294a90a9dcc | 2026-10-05 | Warnings | M012 1043400 9D2RTI9KYH V9BI9B5YI2 362O9ITL9D |
| Vicks DayQuil and Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 416c6674-e4aa-6375-e054-00144ff8d46c | 2026-10-05 | Warnings | M012 1113705 1043400 2637726 |
| Vicks NyQuil Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fc9e05a5-ca03-faa2-e053-6294a90a0d58 | 2026-10-05 | Warnings | M012 1043400 9D2RTI9KYH V9BI9B5YI2 362O9ITL9D |
| Vicks DayQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 16272e93-0062-935a-e063-6294a90a0dda | 2026-10-05 | Warnings | M012 9D2RTI9KYH 362O9ITL9D |
| Vicks DayQuil and Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 17dfc247-fcb6-9659-e063-6294a90a2523 | 2026-10-05 | Warnings | M012 1043400 |
| Vicks NyQuil FOR PEOPLE WITH DIABETES COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 16275c74-32a6-25f4-e063-6394a90a6717 | 2026-10-05 | Warnings | M012 9D2RTI9KYH V9BI9B5YI2 362O9ITL9D |
| Vicks VapoCool Sore Throat | BENZOCAINE AND MENTHOL | The Procter & Gamble Manufacturing Company | befe6da7-1ccb-6ae4-e053-2a95a90ae4cf | 2026-10-05 | Warnings | L7T10EIP3A |
| Vicks VapoDrops | MENTHOL | The Procter & Gamble Manufacturing Company | 3c431baa-c49d-ff3f-e063-6394a90aa12a | 2026-10-05 | Warnings | M012 L7T10EIP3A |
| Vicks Herbal Drops | MENTHOL | The Procter & Gamble Manufacturing Company | 38dd9678-75e8-ac3b-e063-6394a90a72a6 | 2026-10-05 | Warnings | L7T10EIP3A |
| Vicks Vapo Breathers | MENTHOL | The Procter & Gamble Manufacturing Company | 365b3831-5d58-c607-e063-6294a90a39c9 | 2026-10-05 | Warnings | L7T10EIP3A |
| Vicks VapoCOOL Severe Sugar-Free | MENTHOL | The Procter & Gamble Manufacturing Company | 1be4c73d-278f-7333-e063-6294a90a7d6d | 2026-10-05 | Warnings | L7T10EIP3A |
| Vicks Formula 44 Cough Drops | MENTHOL | The Procter & Gamble Manufacturing Company | bb9e483e-095d-8a42-e053-2a95a90ad8d6 | 2026-10-05 | Warnings | L7T10EIP3A |
| VICKS FORMULA 44DM COUGH | DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 05411a51-a49a-96fd-e063-6294a90ae37b | 2026-10-05 | Warnings | M012 9D2RTI9KYH |
| VICKS FORMULA 44DM COUGH and CHEST CONGESTION | DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 05412b91-c1f0-c947-e063-6294a90acd17 | 2026-10-05 | Warnings | M012 9D2RTI9KYH |
| Vicks DayQuil and Vicks NyQuil ELDERBERRY COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 1b569c65-437c-1dbc-e063-6394a90a04aa | 2026-10-05 | Warnings | M012 |
| Nervive Pain Relieving Liquid Roll-on | LIDOCAINE HCL AND MENTHOL | The Procter & Gamble Manufacturing Company | 1e8aeccc-8d00-9886-e063-6394a90ad7a6 | 2026-10-05 | Warnings | L7T10EIP3A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.